Real-world clinical outcomes in BRCA-positive metastatic breast cancer patients treated in the community oncology setting

被引：0
|
作者：
Houts, Arthur C.
Olufade, Temitope O.
Shenolikar, Rahul
Walker, Mark S.
机构：
[1] Vector Oncol, Memphis, TN USA
[2] AstraZeneca, Gaithersburg, MD USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-09-15
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Learning from every patient: Real-world clinical outcomes of patients with metastatic triple-negative breast cancer treated in the community oncology setting.
    Khanna, Anchit
    Bowers, Elani
    Haiderali, Amin
    Slancar, Michael Marian
    Rainey, Natalie Heather
    Teo, Lee Na
    Collins, Ian M.
    Tafreshi, Ali
    Pokharel, Khageshwor
    Sabbah, Ream
    Bohensky, Megan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Real-world outpatient cost of care among patients with breast cancer treated in the US community oncology setting
    Su, Zhaohui
    Shi, Junxin
    Espirito, Janet
    Niehoff, Nicole
    Aguilar, Kathleen M.
    Herms, Lisa
    O'Sullivan, Amy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 385 - 385
  • [3] Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy
    Leticia Varella
    Akaolisa Samuel Eziokwu
    Xuefei Jia
    Megan Kruse
    Halle C. F. Moore
    George Thomas Budd
    Jame Abraham
    Alberto J. Montero
    Breast Cancer Research and Treatment, 2019, 176 : 429 - 434
  • [4] Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy
    Varella, Leticia
    Eziokwu, Akaolisa Samuel
    Jia, Xuefei
    Kruse, Megan
    Moore, Halle C. F.
    Budd, George Thomas
    Abraham, Jame
    Montero, Alberto J.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (02) : 429 - 434
  • [5] Real-world treatment patterns and clinical effectiveness outcomes of eribulin in metastatic breast cancer patients in community oncology centers in the United States
    Mougalian, S. S.
    Kish, J. K.
    Zhang, J.
    Miller, T.
    Liassou, D.
    Laney, J.
    Iyer, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S369 - S369
  • [6] Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer
    Atchley, Deann P.
    Albarracin, Constance T.
    Lopez, Adriana
    Valero, Vicente
    Amos, Christopher I.
    Gonzalez-Angulo, Ana Maria
    Hortobagyi, Gabriel N.
    Arun, Banu K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (26) : 4282 - 4288
  • [7] Real-world clinical outcomes and treatment patterns among metastatic breast cancer (MBC) patients with germline BRCA mutation (gBRCAmut).
    Quek, Ruben
    Mardekian, Jack
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Comparison of real-world mortality data among patients with glioblastoma (GBM) and metastatic pancreatic cancer (mPC) treated in the community oncology setting
    Cosgrove, David
    Aguilar, Kathleen
    Wang, Yunfei
    Sykes, Charles
    Reinwald, Sarah
    Kubisiak, Emily
    Su, Zhaohui
    Chandrasekaran, Vasu
    Stees, Larisa
    Iyer, Rupa
    Robert, Nicholas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Real-world outcomes of patients with metastatic breast cancer (BC) treated with osteoclast inhibitors (OIs).
    Karimi, Yasmin
    Purington, Natasha
    Liu, Mina
    Kurian, Allison W.
    Sledge, George W.
    Blayney, Douglas W.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Clinical characteristics, treatment patterns, and outcomes for patients with HER2-positive metastatic breast cancer (MBC) treated with pertuzumab (P) in the first-line in a real-world setting
    Robert, N.
    Goertz, H. P.
    Asmar, L.
    Tseng, W. Y.
    Jiao, X.
    Portera, C.
    Yoo, B.
    Patt, D.
    Antao, V.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S288 - S288
12345